Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Therapeutic Drug Carrier Systems
Impact-faktor: 2.9 5-jähriger Impact-Faktor: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Druckformat: 0743-4863
ISSN Online: 2162-660X

Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v20.i23.20
14 pages

Endothelial Cells as Therapeutic Targets in Cancer: New Biology and Novel Delivery Systems

J. C. Murray
CRUK Tumour Cytokine Biology Group, Wolfson Digestive Diseases Centre, University Hospital, Nottingham NG7 24H, UK
S. Moein Moghimi
Molecular Targeting and Polymer Toxicology Group, School of Pharmacy and Biomolecular Sciences, Cockcroft Building, University of Brighton, Brighton BN2 4GJ, UK


The significance of the endothelial cell as a target for antitumor therapy has been recognized for some time, but so far the results of clinical trials exploiting this approach have not been encouraging. The subject is likely to gain new momentum, however, following a number of important recent findings that shed new light on the origins and nature of tumor vasculature. Coupled with rapid developments in the use of phage-displayed peptide libraries to characterize the human vascular map, as well as highly selective delivery systems, this new understanding of tumor vascular biology should provide many fresh and exciting avenues to explore.

Articles with similar content:

The effective role of hydroxyapatite-based composites in anti-cancer drug delivery systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.33, 2016, issue 1
Samaneh Saber-Samandari
The Effective Role of Hydroxyapatite Based Composites in Anticancer Drug Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.33, 2016, issue 1
Saeed Saber-Samandari, Nader Nezafati, Samaneh Saber-Samandari
Emerging Receptor Tyrosine Kinase Drug Targets: Implications for Antibody-Based Therapies for Oncology and Immunologic Disorders
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 5-6
Diego Alvarado, Andrew J. Garton, Theresa M. LaVallee, Gerald McMahon, E. Sergio Trombetta, Richard Gedrich
Bacterial Toxins in Cancer Immunotherapy
Forum on Immunopathological Diseases and Therapeutics, Vol.4, 2013, issue 3-4
Lenka Sadilkova, Irena Adkins, Lenka Palova-Jelinkova
Gene Expression in Stem Cells
Critical Reviews™ in Eukaryotic Gene Expression, Vol.19, 2009, issue 4
Yu Liang, Criss Walworth, Iain Russell, Caifu Chen